Patients using these agents may suffer from retrograde ejaculation, nausea, dizziness, palpitation, and orthostatic hypotension.3,6,16,17 From this point of view, new agents such as β3AR agonists have been introduced as MET. The gene discussed is ADRB3; the disease is Retrograde ejaculation.